酶诱导抗癫痫药(ASDs)患者维生素D补充不足与骨病风险增加相关
Low vitamin D use in patients on enzyme-inducing antiseizure drugs raises concerns
酶诱导抗癫痫药(ASDs)使用与患者骨病风险增加相关(调整后OR 1.51),且维生素D补充不足现象普遍(酶诱导组20.7% vs 非酶诱导组16.2%)。Ali等指出,尽管皮质类固醇使用(OR 1.56)和慢性肾病(OR 1.61)独立增加骨病风险,但肥胖具有保护作用(OR 0.82),提示临床实践中存在指南推荐与实际执行间的显著差距。
Enzyme-inducing antiseizure drugs (ASDs) are associated with increased odds of incident osteoporosis or osteopenia, but vitamin D supplementation is underutilized, according to a study presented at the annual meeting of the American Neurological Association, held from Oct. 17 to 20 in San Diego.
Mehreen Ali, from Carle Illinois College of Medicine in Urbana, and colleagues used data from the All of Us Research Program to examine new diagnoses of osteoporosis or osteopenia after patients received a first prescription for an ASD. A total of 1,395 adults on enzyme-inducing ASDs were compared to 15,374 adults on non-enzyme-inducing ASDs. Vitamin D supplementation initiated after ASD exposure was ascertained.
The researchers found that enzyme-inducing ASD use was independently associated with increased odds of incident osteoporosis or osteopenia after full adjustment for age, sex, corticosteroid use, chronic kidney disease (CKD), obesity and vitamin D supplementation (adjusted odds ratio, 1.51). The association was not due to measured confounders, with minimal attenuation seen from unadjusted to adjusted estimates.
Corticosteroid use and CKD were independently associated with bone disease (odds ratios, 1.56 and 1.61, respectively), while obesity was protective (odds ratio, 0.82). Only 20.7% of patients on enzyme-inducing ASDs received vitamin D supplementation postdiagnosis compared with 16.2% of patients on non-enzyme-inducing ASDs.
"What's most striking about this finding is not the bone disease risk itself—we expected that—but how few patients were receiving vitamin D supplementation, suggesting there is a significant gap between what guidelines recommend and what is actually happening in clinical practices," Ali said.
Who's behind this story?
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Copyright © 2026 HealthDay. All rights reserved.
Citation: Low vitamin D use in patients on enzyme-inducing antiseizure drugs raises concerns (2026, October 20) retrieved 20 October 2026 from https://medicalxpress.com/news/2026-10-vitamin-d-patients-enzyme-antiseizure.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com